Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases-Reference-Cited by-同舟云学术

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

Published:2018-04 Issue:4 Volume:29 Page:959-965
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Vokes E.E.^ORCID,Ready N.,Felip E.,Horn L.,Burgio M.A.,Antonia S.J.,Arén Frontera O.,Gettinger S.,Holgado E.,Spigel D.,Waterhouse D.,Domine M.,Garassino M.,Chow L.Q.M.,Blumenschein G.,Barlesi F.,Coudert B.,Gainor J.,Arrieta O.,Brahmer J.,Butts C.,Steins M.,Geese W.J.,Li A.,Healey D.,Crinò L.

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/29/4/959/24702780/mdy041.pdf

Reference21 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. American Cancer Society. Lung cancer (non-small cell). American Cancer Society website. http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-what-is-non-small-cell-lung-cancer (8 June 2016, date last accessed).

3. OPDIVO® (Nivolumab) [Package Insert],2018

4. OPDIVO® (Nivolumab) [Summary of Product Characteristics],2018

5. Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer;Borghaei;N Engl J Med,2015

Cited by 396 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The regulating properties of Sanqi that enhances PD-1 inhibitors effects in lung cancer revealed by metabolomic and microbiome analyses;Journal of Functional Foods;2024-09

2. Emerging Roles of CircRNA-miRNA Networks in Cancer Development and Therapeutic Response;Non-coding RNA Research;2024-09

3. DCE-CT parameters as new functional imaging biomarkers at baseline and during immune checkpoint inhibitor therapy in patients with lung cancer – a feasibility study;Cancer Imaging;2024-08-13

4. Gut resistome of NSCLC patients treated with immunotherapy;Frontiers in Genetics;2024-08-07

5. Construction of a nomogram model based on biomarkers for liver metastasis in non‐small cell lung cancer;Thoracic Cancer;2024-08-04